A biological basis for depression in pancreatic cancer

HPB

Volumn 16, Issue 8, 2014, Pages 740-743

  Botwinick, Isadora C ^a   Pursell, Lisa ^b   Yu, Gary ^b   Cooper, Tom ^c   Mann, J John ^b   Chabot, John A ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

^c Nathan Kline Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENIC ACID; KYNURENINE; QUINOLINIC ACID; TRYPTOPHAN;

ADULT; AGED; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BLOOD LEVEL; CLINICAL ARTICLE; DEPRESSION; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY PANCREATIC CANCER; HUMAN; IMMUNE DEFICIENCY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PANCREAS ADENOCARCINOMA; TUMOR VOLUME; ADENOCARCINOMA; AFFECT; BLOOD; COMPLICATION; LYMPH NODE METASTASIS; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADENOCARCINOMA; AFFECT; AGED; AGED, 80 AND OVER; DEPRESSION; FEMALE; HUMANS; KYNURENINE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS; SIGNAL TRANSDUCTION; SURVEYS AND QUESTIONNAIRES; TRYPTOPHAN; TUMOR BURDEN;

EID: 84904287280     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12201     Document Type: Article

References (16)

1. Green AI, Austin CP,. (1993) Psychopathology of pancreatic cancer. A psychobiologic probe. Psychosomatics 34: 208-221.
2. Fras I, Litin EM, Pearson JS,. (1967) Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry 123: 1553-1562.
3. Holland JC, Korzun AH, Tross S, Silberfarb P, Perry M, Comis R, et al. (1986) Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 143: 982-986.
4. Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, et al. (1995) Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 13: 748-755.
5. Hopko DR, Bell JL, Armento ME, Robertson SM, Hunt MK, Wolf NJ, et al. (2008) The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 26: 31-51.
6. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11: 570-579.
7. Pi LG, Tang AG, Mo XM, Luo XB, Ao X,. (2009) More rapid and sensitive method for the simultaneous determination of tryptophan and kynurenic acid by HPLC. Clin Biochem 42: 420-425.
8. Zhang X, He Y, Ding M,. (2009) Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. J Chromatogr B 877: 1678-1682.
9. Heyes MP, Markey SP,. (1988) Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic l-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem 174: 349-359.
10. Russo S, Kema IP, Fokkema MR, Boon JC, Willemse PH, de Vries EG, et al. (2003) Tryptophan as a link between psychopathology and somatic states. Psychosom Med 65: 665-671.
11. Müller N, Schwarz MJ,. (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12: 988-1000.
12. Witkiewicz A, Williams TK, Cozzitorto J, Durkan B, Showalter SL, Yeo CJ, et al. (2008) Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. J Am Coll Surg 206: 849-854; discussion 854-856.
13. Witkiewicz AK, Costantino CL, Metz R, Muller AJ, Prendergast GC, Yeo CJ, et al. (2009) Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target. J Am Coll Surg 208: 781-787; discussion 787-789.
14. Katz JB, Muller AJ, Prendergast GC,. (2008) Indoleamine 2,3-dioxygenase in T cell tolerance and tumoral immune escape. Immunol Rev 222: 206-221.
15. Löb S, Königsrainer A, Rammensee HG, Opelz G, Terness P,. (2009) Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 9: 445-452.
16. Källberg E, Wikström P, Bergh A, Ivars F, Leanderson T,. (2010) Indoleamine 2,3-dioxygenase (IDO) activity influence tumour growth in the TRAMP prostate cancer model. Prostate 70: 1461-1470.